CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease.

ABSTRACT: Parkinson's disease (PD) and other chronic and debilitating neurodegenerative diseases (NDs) impose a substantial medical, emotional, and financial burden on individuals and society. The origin of PD is unknown due to a complex combination of hereditary and environmental risk factors. However, over the last several decades, a significant amount of available data from clinical and experimental studies has implicated neuroinflammation, oxidative stress, dysregulated protein degradation, and mitochondrial dysfunction as the primary causes of PD neurodegeneration. The new gene-editing techniques hold great promise for research and therapy of NDs, such as PD, for which there are currently no effective disease-modifying treatments. As a result, gene therapy may offer new treatment options, trans

SUBMITTER: Rahman MU 

PROVIDER: S-EPMC9229276 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature